首頁 > 市場調查報告書 > 醫療設備

體外診斷

市場調查報告書

商品編碼

2050458

D-二聚體檢測市場：依產品類型、檢測類型、方法、應用、最終用戶和地區分類

D Dimer Test Market, By Product Type, By Test Type, By Method, By Application, By End User, By Geography

出版日期: 2026年03月17日 | 出版商:

Coherent Market Insights | 英文 165 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

據估計，D-二聚體檢測市場在2026年的價值為20.5億美元，預計到2033年將達到31.5億美元。預計從2026年到2033年，其複合年成長率將達到6.3%。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	250億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	6.30%	2033年市場規模預測：	31.5億美元

全球D-二聚體檢測市場是診斷檢測產業的重要組成部分，其主要功能是測量血液中纖維蛋白分解產物，以評估血栓形成和纖溶活性。 D-二聚體檢測已成為重要的診斷工具，主要用於排除靜脈血栓栓塞症（VTE），包括深層靜脈栓塞症和肺動脈栓塞，同時也可作為多種心血管疾病和發炎性疾病的有效標記。此檢測的高陰性預測值在急診醫學和門診環境中尤其重要，能夠幫助醫護人員快速做出臨床決策，避免不必要的影像檢查。

該市場涵蓋多種調查方法，包括酵素免疫分析法(ELISA)、乳膠凝集測試和免疫比濁法，並透過從照護現場設備到高通量臨床實驗室分析儀等多種平台提供服務。隨著心血管疾病盛行率的上升、人口老化以及人們對血栓併發症認知的提高（尤其是在 COVID-19 大流行期間，D-二聚體水平成為一項關鍵監測指標），該市場經歷了顯著成長和技術進步，推動了檢測靈敏度、特異性和快速檢測能力的創新。

市場動態

全球D-二聚體檢測市場受多種關鍵因素驅動，其中包括全球心血管疾病和靜脈血栓栓塞症發病率的上升。這顯著增加了對可靠診斷工具的需求。全球人口老化，尤其是在已開發地區，是市場成長的主要促進因素，因為老年人發生血栓事件的風險更高，需要定期監測和篩檢。新冠肺炎疫情的爆發成為重要的催化劑，凸顯了D-二聚體作為疾病嚴重程度和併發症預後標記物的重要性，促使醫療機構廣泛採用此檢測方法。就地檢驗設備的技術進步和檢測準確性的提高增強了市場的可及性和臨床效用。然而，市場也存在一些顯著的局限性，例如檢測的特異性有限。多種血栓症疾病，包括感染疾病、懷孕、癌症和炎症，都可能導致D-二聚體水平升高，從而造成假陽性結果和不必要的干涉。

開發中國家的成本限制以及對能夠準確解讀檢測結果的熟練醫護人員的需求，也為市場擴張帶來了挑戰。此外，不同檢測平台和調查方法之間缺乏標準化，導致結果解讀不一致。儘管存在這些挑戰，但仍存在巨大的機遇，尤其是在偏遠地區和醫療資源匱乏的環境中擴大即時檢測能力、開發更具特異性的生物標記以補充D-二聚體檢測以及利用人工智慧提高結果解讀的準確性等方面。新興市場對預防醫學和早期診斷日益成長的興趣，以及不斷成長的醫療保健支出，為市場擴張和創新提供了巨大的成長前景。

本次調查的主要特點

本研究確定了各個細分市場的潛在商機，並說明了該市場具有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和核准、市場趨勢、區域展望以及領先企業採取的競爭策略。
本研究基於以下參數分析了全球 D-二聚體檢測市場的主要參與者：公司亮點、產品系列、關鍵亮點、財務表現和策略。
透過利用本報告中的見解，企業行銷負責人和經營團隊將能夠就未來的產品發布、產品升級、市場擴張和行銷策略做出明智的決策。
這份全球 D-二聚體檢測市場報告的目標受群眾外包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師等行業相關人員相關者。
透過利用全球 D-二聚體檢測市場分析中使用的各種策略矩陣，相關人員可以更輕鬆地做出決策。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲國家
歐洲
- 德國
- 英國
- 西班牙
- 法國
- 義大利
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- 澳洲
- 韓國
- ASEAN
- 其他亞太國家
中東
- 海灣合作理事會國家
- 以色列
- 其他中東國家
非洲
- 南非
- 北非
- 中非

第10章競爭格局

Siemens Healthineers
Roche Diagnostics
Abbott Diagnostics
Beckman Coulter
Sysmex Corporation
bioMerieux
Diagnostica Stago
Werfen（Instrumentation Laboratory）
Sekisui Diagnostics
Randox Laboratories
DiaSys Diagnostic Systems
Snibe（Shenzhen New Industries Biomedical）
Getein Biotech
Boditech Med
Wondfo Biotech

第11章分析師建議

機會分析
分析師意見
Coherent Opportunity Map

第12章參考文獻與調查方法

參考
調查方法
關於本公司

簡介目錄

Product Code: CMI8608

D Dimer Test Market is estimated to be valued at USD 2.05 Bn in 2026 and is expected to reach USD 3.15 Bn by 2033, growing at a compound annual growth rate (CAGR) of 6.3% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 2.05 Bn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	6.30%	2033 Value Projection:	USD 3.15 Bn

The global D dimer test market represents a critical segment within the diagnostic testing industry, focusing on the measurement of fibrin degradation products in blood to assess thrombotic and fibrinolytic activity. D-dimer testing has emerged as an essential diagnostic tool primarily utilized for ruling out Venous Thromboembolism (VTE), including deep vein thrombosis and pulmonary embolism, while also serving as a valuable marker in various cardiovascular and inflammatory conditions. The test's high negative predictive value makes it particularly valuable in emergency medicine and outpatient settings, enabling healthcare providers to make rapid clinical decisions and avoid unnecessary imaging procedures.

The market encompasses various testing methodologies including Enzyme-Linked Immunosorbent Assays (ELISA), latex agglutination, and immunoturbidimetric assays, offered through different platforms ranging from point-of-care devices to high-throughput laboratory analyzers. With the increasing prevalence of cardiovascular diseases, aging populations, and heightened awareness of thrombotic complications, particularly following the COVID-19 pandemic where D-dimer levels became a crucial monitoring parameter, the market has witnessed substantial growth and technological advancement, driving innovation in assay sensitivity, specificity, and rapid testing capabilities.

Market Dynamics

The global D dimer test market is propelled by several key drivers, including the rising incidence of cardiovascular diseases and venous thromboembolism worldwide, which has significantly increased the demand for reliable diagnostic tools. The aging global population, particularly in developed regions, contributes substantially to market growth as elderly individuals face higher risks of thrombotic events, necessitating regular monitoring and screening. The COVID-19 pandemic emerged as a major catalyst, highlighting D-dimer's importance as a prognostic marker for disease severity and complications, leading to widespread adoption across healthcare facilities. Technological advancements in point-of-care testing devices and improved assay accuracy have enhanced market accessibility and clinical utility. However, the market faces notable restraints including the test's limited specificity, as elevated D-dimer levels can occur in various non-thrombotic conditions such as infection, pregnancy, cancer, and inflammation, potentially leading to false positives and unnecessary interventions.

Cost constraints in developing economies and the requirement for skilled healthcare professionals to interpret results accurately also pose challenges to market expansion. Additionally, the lack of standardization across different testing platforms and methodologies creates inconsistencies in results interpretation. Despite these challenges, significant opportunities exist in expanding point-of-care testing capabilities, particularly in remote and resource-limited settings, developing more specific biomarkers to complement D-dimer testing, and leveraging artificial intelligence for improved result interpretation. The growing emphasis on preventive healthcare and early diagnosis, coupled with increasing healthcare expenditure in emerging markets, presents substantial growth prospects for market expansion and innovation.

Key features of the study

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global D dimer test market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Siemens Healthineers, Roche Diagnostics, Abbott Diagnostics, Beckman Coulter, Sysmex Corporation, bioMerieux, Diagnostica Stago, Werfen (Instrumentation Laboratory), Sekisui Diagnostics, Randox Laboratories, DiaSys Diagnostic Systems, Snibe (Shenzhen New Industries Biomedical), Getein Biotech, Boditech Med, and Wondfo Biotech
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global D dimer test market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global D dimer test market

Market Segmentation

Product Type Insights (Revenue, USD Bn, 2021 - 2033)
Reagents and Kits
Analyzers
Consumables and Accessories
Test Type Insights (Revenue, USD Bn, 2021 - 2033)
Laboratory-Based D-Dimer Test
Point-of-Care (POC) D-Dimer Test
Method Insights (Revenue, USD Bn, 2021 - 2033)
Enzyme-Linked Immunosorbent Assay (ELISA)
Latex-Enhanced Immunoassay
Fluorescence Immunoassay
Others (e.g., Immunoturbidimetric Assay)
Application Insights (Revenue, USD Bn, 2021 - 2033)
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Disseminated Intravascular Coagulation (DIC)
Other Thrombotic Conditions
End User Insights (Revenue, USD Bn, 2021 - 2033)
Hospitals
Diagnostic Laboratories
Academic and Research Institutes
Ambulatory Surgical Centers
Others (e.g., Home Care Settings)
Regional Insights (Revenue, USD Bn, 2021 - 2033)
North America
- U.S.
- Canada
Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
Middle East
- GCC Countries
- Israel
- Rest of Middle East
Africa
- South Africa
- North Africa
- Central Africa
Key Players Insights
Siemens Healthineers
Roche Diagnostics
Abbott Diagnostics
Beckman Coulter
Sysmex Corporation
bioMerieux
Diagnostica Stago
Werfen (Instrumentation Laboratory)
Sekisui Diagnostics
Randox Laboratories
DiaSys Diagnostic Systems
Snibe (Shenzhen New Industries Biomedical)
Getein Biotech
Boditech Med
Wondfo Biotech

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Global D Dimer Test Market, By Product Type
- Global D Dimer Test Market, By Test Type
- Global D Dimer Test Market, By Method
- Global D Dimer Test Market, By Application
- Global D Dimer Test Market, By End User
- Global D Dimer Test Market, By Region

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
Driver
Restraint
Opportunity
Impact Analysis
Key Developments
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario
Industry Trends

4. Global D Dimer Test Market, By Product Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Reagents and Kits
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Analyzers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Consumables and Accessories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

5. Global D Dimer Test Market, By Test Type, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Laboratory-Based D-Dimer Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Point-of-Care (POC) D-Dimer Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

6. Global D Dimer Test Market, By Method, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Enzyme-Linked Immunosorbent Assay (ELISA)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Latex-Enhanced Immunoassay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Fluorescence Immunoassay
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others (e.g., Immunoturbidimetric Assay)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

7. Global D Dimer Test Market, By Application, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Deep Vein Thrombosis (DVT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Pulmonary Embolism (PE)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Disseminated Intravascular Coagulation (DIC)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Other Thrombotic Conditions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

8. Global D Dimer Test Market, By End User, 2021 - 2033, (USD Bn)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Diagnostic Laboratories
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Academic and Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
Others (e.g., Home Care Settings)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)

9. Global D Dimer Test Market, By Region, 2021 - 2033, Value (USD Bn)

Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Brazil
  - Argentina
  - Mexico
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - Germany
  - U.K.
  - Spain
  - France
  - Italy
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Test Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Method, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
  - South Africa
  - North Africa
  - Central Africa

10. Competitive Landscape

Siemens Healthineers
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Roche Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Abbott Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Beckman Coulter
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sysmex Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
bioMerieux
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Diagnostica Stago
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Werfen (Instrumentation Laboratory)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Sekisui Diagnostics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Randox Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
DiaSys Diagnostic Systems
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Snibe (Shenzhen New Industries Biomedical)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Getein Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Boditech Med
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Wondfo Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies